Virtual Medicinal Product (VMP)
-
Lamivudine 100mg tablets
Name Details
|
Current Name
Lamivudine 100mg tablets
|
Start Date
12-02-2003
|
End Date
|
Unit Dose & Form Information
- DF Indicator
- Discrete
- UDFS Indicator
- 1
- UDFS UOM
- tablet
- Unit Dose UOM
- tablet
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Oral
- Form
- Oral tablet
- Ontology Form/Route
- tablet.oral
- Name Basis
- rINN - Recommended International Non-proprietary
Codes
- ATC Code
-
J05AF05
| BNF |
|
Current BNF
05030100
|
Start Date
04-04-2022
|
End Date
|
|
Previous BNF
05030100
|
Start Date
23-02-2005
|
End Date
03-04-2022
|
SNOMED Codes
|
Code
|
Start Date
|
End Date
|
| 41789911000001107 |
12-05-2023 |
|
| 324829002 |
12-02-2003 |
11-05-2023 |
VMP Ingredients
VMP ingredients table
| Lamivudine |
Based on Ingredient Substance |
|
100 mg |
|
Name
Lamivudine
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
100
Strength and UOM (Dmr)
Parent Products
-
VTM
Lamivudine
-
VMP
(Current) Lamivudine 100mg tablets
Virtual Medicinal Product Pack (VMPP) Information